Wills Eye expert discusses what patients need to know about Age-Related Macular Degeneration

Carl D. Regillo, MD Chief of the Wills Eye Hospital Retina Service discusses what patients need to know about Age-Related Macular Degeneration (AMD).

"It's very important for people to know they have AMD, because we do have some very effective treatments," Dr. Regillo says.

"For people over the age of 60, it's not uncommon to see some degenerative changes of the macula, and there are two forms," Dr. Regillo says. "The dry, early stage usually doesn't have many symptoms with it, if the condition stays dry."

"The more severe 'wet stage' causes potentially severe vision loss if not treated," Dr. Regillo says. "But, we do have good treatments, and if we detect the 'wet form' early in its course, we can retain relatively good vision in many patients." Dr. Regillo says.

Patients over the age of 60 should know:
• Macular degeneration beyond age 60 is normal
• 'Dry' Age-Related Macular Degeneration can be treated with a vitamin regimen to prevent it from advancing to the more serious 'Wet' form
• Any sudden vision changes should be checked immediately for change from 'Dry' to 'Wet' form of the condition
• Early detection of 'Wet' stage AMD is vital to treat and retain vision

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights on protein degraders open doors to treatment for 'undruggable' diseases